Skip to main content
Fig. 5 | BMC Infectious Diseases

Fig. 5

From: Title: role of matrix metalloproteinase −9 in progression of tuberculous meningitis: a pilot study in patients at different stages of the disease

Fig. 5

Log10 CFUs of Mycobacterium tuberculosis H37Rv infected C6 glioma cells after 5 days of treatment. Group I: uninfected cells, Group II: Untreated C6 cells infected with Mycobacterium tuberculosis H37Rv, Group III: Infected C6 cells treated with Dexamethasone, Group IV: Infected C6 cells treated with SB-3CT, Group V: Infected C6 cells treated with antitubercular drugs (Isoniazid + Rifampicin + Pyrazinamide) Group VI: Infected cells treated with antitubercular drugs along with dexamethasone, Group VII: Infected cells treated with antitubercular drugs along with SB-3CT. Values are mean ± SD of cells processed in triplicate. *** p < 0.001, respect to Group II

Back to article page